LATEST NEWS

Hafnium oxide nanoparticles activated by SBRT for the treatment of hepatocellular carcinoma and liver metastasis: a phase I/II trial

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.